ID
43728
Description
Study ID: 100527 Clinical Study ID: B2E100527 Study Title: A randomised, double blind, placebo controlled, parellel group study to examine the efficacy, safety, tolerability and systemic pharmacokinetic profile of repeated inhaled doses of GSK159797 Sponsor: GlaxoSmithKline Phase: phase 2 Study Recruitment Status: Completed Generic Name: milveterol Trade Name: Milveterol Study Indication: Pulmonary Disease, Chronic Obstructive
Keywords
Versions (2)
- 6/18/17 6/18/17 -
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Electrocardiogram Abnormalities Form - GSK Milveterol COPD 100527
Electrocardiogram Abnormalities Form - GSK Milveterol COPD 100527
Similar models
Electrocardiogram Abnormalities Form - GSK Milveterol COPD 100527
C0013798 (UMLS CUI [1,2])
C2985739 (UMLS CUI [1,2])
C1331539 (UMLS CUI [2,1])
C1704258 (UMLS CUI [2,2])
C0522055 (UMLS CUI [1,2])
C0522055 (UMLS CUI [1,2])